"Anchor Neuroscience is a clinical research facility co-located with The Anchor Clinic in Pensacola, Florida, an independent, multi-specialty outpatient behavioral medicine group. Our clinical trials division specializes in adults as well as pediatric populations. Our providers practice within a variety of specialties including psychiatry, neuropsychology, and clinical psychology. Our staff is comprised of certified research coordinators and certified research professionals who assist our investigators in properly administering clinical trials."

During the past decade, Anchor Neuroscience conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anchor Neuroscience" #1 sponsor was "Neurotrope Bioscience, Inc." with 2 trials, followed by "Cortexyme Inc." with 1 trials sponsored, "EIP Pharma Inc" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Neuronetics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anchor Neuroscience" #1 collaborator was "Worldwide Clinical Trials" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Anchor Neuroscience" are "Alzheimer Disease" (4 trials), "Alzheimer's Disease" (1 trials), "Dementia With Lewy Bodies" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "Anchor Neuroscience" in a lesser frequency.

Most popular intervention types in "Anchor Neuroscience" are "Drug" (6 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Active NeuroStar® Transcranial Magnetic Stimulation (TMS)" (1 trials), "Bryostatin" (1 trials), "Bryostatin 1" (1 trials) and "COR388 capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anchor Neuroscience" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Anchor Neuroscience". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Anchor Neuroscience, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Anchor Neuroscience, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".